SISTEMA INTEGRAL DE INFORMACIÓN ACADÉMICA - PÚBLICO

Mehta R.
(Autor externo)

Obras con ISBN:0
Documentos en revistas:59
Colaboraciones en Tesis:0
Patentes:0
Obras con ISBN:No hay obras de este autor.
Documentos en revistas:
1.- Analysis of a deeply-phenotyped familial hypercholesterolemia cohort from Mexico shows a role for both rare and common alleles across known dyslipidemia genes and reveals structural variation in a novel locus (2025)
 
2.- First confirmed human case of H5N2 virus infection in Mexico: an emerging zoonotic concern (2024)
 
3.- Poincaré maps on population-based data of subjects with a confirmatory diagnosis of COVID-19 (2023)
 
4.- Arterial Stiffness and HbA1c: Association Mediated by Insulin Resistance in Hispanic Adults (2022)
 
5.- Physiological Network Is Disrupted in Severe COVID-19 (2022)
 
6.- Mexican clinical practice guideline for the diagnosis and treatment of dyslipidemias and atherosclerotic cardiovascular disease (2022)
 
7.- Very Low Vitamin D Levels are a Strong Independent Predictor of Mortality in Hospitalized Patients with Severe COVID-19: Hypovitaminosis D and COVID-19 mortality (2022)
 
8.- Adaptive Metabolic and Inflammatory Responses Identified Using Accelerated Aging Metrics Are Linked to Adverse Outcomes in Severe SARS-CoV-2 Infection (2021)
 
9.- Effects on capsicum annuum plants colonized with trichoderma atroviride P. Karst strains genetically modified in taswo1, a gene coding for a protein with expansin-like activity (2021)
 
10.- LCAT deficiency: a systematic review with the clinical and genetic description of Mexican kindred (2021)
 
11.- Increased visceral fat accumulation modifies the effect of insulin resistance on arterial stiffness and hypertension risk (2021)
 
12.- Impact of undiagnosed type 2 diabetes and pre-diabetes on severity and mortality for SARS-CoV-2 infection (2021)
 
13.- Familial hypercholesterolemia in Mexico: Initial insights from the national registry (2021)
 
14.- Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) (2021)
 
15.- In silico Characterization of microRNAs and Their Target Transcripts from Cranberry (Vaccinium macrocarpon) (2020)
 
16.- Clinical characterization of data-driven diabetes subgroups in Mexicans using a reproducible machine learning approach (2020)
 
17.- High Molecular Weight ACTH-Precursor Presence in a Metastatic Pancreatic Neuroendocrine Tumor Causing Severe Ectopic Cushing's Syndrome: A Case Report (2020)
 
18.- Intermittent Fasting as Part of the Management for T2DM: from Animal Models to Human Clinical Studies (2020)
 
19.- Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action (2020)
 
20.- Fibroblast growth factor 21 and browning of white adipose tissue (2019)
 
21.- Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial (2019)
 
22.- Dapagliflozin and cardiovascular outcomes in type 2 diabetes (2019)
 
23.- Genome Wide Computational Identification of Tuna (Thunnus orientalis) MicroRNAs and Their Targets (2018)
 
24.- Identification of a threshold to discriminate fasting hypertriglyceridemia with postprandial values (2018)
 
25.- METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes (2018)
 
26.- The development of the Mexican Familial Hypercholesterolemia (FH) National Registry (2018)
 
27.- Insulin Adherence in Type 2 Diabetes in Mexico: Behaviors and Barriers (2018)
 
28.- A higher fructose intake is associated with greater albuminuria in subjects with type 2 diabetes mellitus (2018)
 
29.- Mexican consensus on lysosomal acid lipase deficiency diagnosis (2018)
 
30.- Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) (2018)
 
31.- Rivaroxaban with or without aspirin in stable cardiovascular disease (2017)
 
32.- Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy (2017)
 
33.- Setting the lipid component of the diet: A work in process (2017)
 
34.- Papel actual de empagliflozina en el control glucémico de pacientes con diabetes tipo 2: De la investigación preclínica a los estudios fase III (2015)
 
35.- Factors associated with postprandial lipemia and apolipoprotein a-v levels in individuals with familial combined hyperlipidemia (2014)
 
36.- Determinants of VLDL composition and apo B-containing particles in familial combined hyperlipidemia (2014)
 
37.- Innovative models for the empowerment of patients with type 2 diabetes: The CAIPaDi program (2014)
 
38.- Effect of tomato consumption on high-density lipoprotein cholesterol level: A randomized, single-blinded, controlled clinical trial (2013)
 
39.- Metformin and improvement of the hepatic insulin resistance index independent of anthropometric changes (2012)
 
40.- Sensorineural hearing loss-a common finding in early-onset type 2 diabetes mellitus (2012)
 
41.- Association of Alanine Aminotransferase Levels (ALT) with the Hepatic Insulin Resistance Index (HIRI): a cross-sectional study (2012)
 
42.- Management of type 2 diabetes: More evidence is required to address the clinical and contextual facets (2011)
 
43.- UKPDS Risk Engine, DECODE and diabetes PHD models for the estimation of cardiovascular risk in patients with diabetes (2010)
 
44.- Significant increment in the prevalence of overweight and obesity documented between 1994 and 2008 in Mexican college students (2010)
 
45.- Epidemiology of diabetes in the elderly [Epidemiología de la diabetes en el anciano] (2010)
 
46.- Beta-cell adenomas without hyperinsulinemia with use of highly specific insulin radioimmunoassays: case report and review of literature. (2010)
 
47.- Radioiodine Treatment in Autoimmune Hyperthyroidism: Analysis of Outcomes in Relation to Dosage (2007)
 
48.- The continous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: Results of a phase II study (2007)
 
49.- The ATP-binding cassette transporter subfamily A member 1 (ABC-A1) and type 2 diabetes: An association beyond HDL cholesterol (2007)
 
50.- Analysis of fasting plasma glucose values for optimal detection of abnormal responses on the oral glucose tolerance test in at-risk study subjects (2007)
 
51.- Design and validation of a population-based definition of the metabolic syndrome (2006)
 
52.- Management of the metabolic syndrome as a strategy for preventing the macrovascular complications of type 2 diabetes: controversial issues. (2005)
 
53.- The metabolic syndrome: A concept hard to define (2005)
 
54.- Familial combined hyperlipidemia: Controversial aspects of its diagnosis and pathogenesis (2004)
 
55.- Epidemiology of the metabolic abnormalities in patients with HIV infection [Epidemiología de las anormalidades metabólicas en pacientes con infección por VIH] (2004)
 
56.- Ciprofibrate therapy in patients with hypertriglyceridemia and low high density lipoprotein (HDL)-cholesterol: Greater reduction of non-HDL cholesterol in subjects with excess body weight (The CIPROAMLAT study) (2004)
 
57.- The body mass index is a less-sensitive tool for detecting cases with obesity-associated co-morbidities in short stature subjects (2004)
 
58.- Genetic defects of beta cell function: (MODY) application of molecular biology to clinical medicine (2003)
 
59.- Development and validation of a tool for predicting type 2 diabetes in Mexican women of reproductive age ()
 
Colaboraciones en Tesis:No hay tesis de este autor.
Patentes:No hay patentes de este autor.